Uniqure N.V. (QURE)

$27.80 +3.10 (12.55%)
Market Cap 1.42B
Revenue (ttm) 27.12M
Net Income (ttm) -239.56M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -883.33%
Debt to Equity Ratio 0.23
Volume 4,683,000
Avg Vol 2,383,762
Day's Range N/A - N/A
Shares Out 62.29M
Stochastic %K 90%
Beta 0.68
Analysts Strong Sell
Price Target $52.64

Company Profile

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial t...

Industry: Biotechnology
Sector: Healthcare
Phone: 31 20 240 6000
Address:
Paasheuvelweg 25, Amsterdam, Netherlands
freddie04
freddie04 Feb. 3 at 8:41 PM
$QURE Ahhhhh …you’ll see ..early yet with loser Matt
0 · Reply
Longbuy1
Longbuy1 Feb. 3 at 5:59 PM
$QURE never forget these losers.
0 · Reply
stu4
stu4 Feb. 3 at 5:48 PM
$QURE you nailed it !!! More Matt BS…company ran by an ex stock broker ..OH WOW
0 · Reply
MAGA1717
MAGA1717 Feb. 3 at 5:25 PM
$QURE $CLPT 🤡🤡🤡 thx fo yo money asshat…
0 · Reply
CapitalGuidanceFramework
CapitalGuidanceFramework Feb. 3 at 4:57 PM
$QURE $EFX Healthcare and data services
0 · Reply
stu4
stu4 Feb. 3 at 4:00 PM
$QURE Matt made the call to his buddies GTFO !! Falling
1 · Reply
CliffordCapital
CliffordCapital Feb. 3 at 3:55 PM
$PLX poor folks at $SGMO .. there is a possibility that their Fabry therapy never makes it to the market.. obviously good for $PLX but sucks for Fabry patients. Only near term company with another Fabry treatmean is $QURE but their p2 data isn‘t until end of 2027 so I expect they are earliest in the market by the end of the decade…
3 · Reply
BigWickEnergy69
BigWickEnergy69 Feb. 3 at 3:53 PM
$QURE QURE is at WORLDSymposium this week presenting on Fabray data. Afterparties on Monday night get a bit loose as people jockey for position in the new group of colleagues. Some say there were loose lips on topics that one might use to impress colleagues…
1 · Reply
Doom_Gloom_AR
Doom_Gloom_AR Feb. 3 at 3:42 PM
$QURE https://en.hdbuzz.net/wp-content/uploads/2026/01/FOR-RELEASE-Skyhawk_SKY-0515-Nine-Month-Phase-1C-Patient-Data-1-27-26.pdf
1 · Reply
Longbuy1
Longbuy1 Feb. 3 at 3:36 PM
$QURE LOL at shorts
0 · Reply
Latest News on QURE
Alger Small Cap Focus Fund Q4 2025 Portfolio Update

Jan 29, 2026, 1:22 PM EST - 5 days ago

Alger Small Cap Focus Fund Q4 2025 Portfolio Update

EXAS GH NBIS NTRA STVN

uniQure Announces Type A Meeting Scheduled with FDA

Jan 9, 2026, 7:05 AM EST - 25 days ago

uniQure Announces Type A Meeting Scheduled with FDA

uniQure: Now What?

Jan 8, 2026, 3:36 PM EST - 26 days ago

uniQure: Now What?

What's Going On With uniQure Stock On Tuesday?

Dec 16, 2025, 12:17 PM EST - 7 weeks ago

What's Going On With uniQure Stock On Tuesday?

Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years

Dec 7, 2025, 12:01 PM EST - 2 months ago

Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years

Why uniQure Stock Is Trading Lower After FDA Meeting Update

Dec 4, 2025, 1:30 PM EST - 2 months ago

Why uniQure Stock Is Trading Lower After FDA Meeting Update

uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease

Dec 4, 2025, 7:05 AM EST - 2 months ago

uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease

Diamond Hill International Strategy Q3 2025 Performance Review

Nov 17, 2025, 8:59 AM EST - 2 months ago

Diamond Hill International Strategy Q3 2025 Performance Review

BABA HDB TSM

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE

Nov 14, 2025, 4:17 AM EST - 2 months ago

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm

Nov 12, 2025, 10:00 AM EST - 2 months ago

QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm

From Setback To Surge: UniQure's Huntington's Hope Is Poised For Upside

Nov 10, 2025, 12:44 PM EST - 3 months ago

From Setback To Surge: UniQure's Huntington's Hope Is Poised For Upside

uniQure N.V. (QURE) Q3 2025 Earnings Call Transcript

Nov 10, 2025, 11:11 AM EST - 3 months ago

uniQure N.V. (QURE) Q3 2025 Earnings Call Transcript

uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 10, 2025, 7:05 AM EST - 3 months ago

uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update

uniQure to Announce Third Quarter 2025 Financial Results

Nov 6, 2025, 7:05 AM EST - 3 months ago

uniQure to Announce Third Quarter 2025 Financial Results

UniQure Shares Drop After FDA Shifts Stance On Huntington's Gene Therapy Data

Nov 3, 2025, 1:04 PM EST - 3 months ago

UniQure Shares Drop After FDA Shifts Stance On Huntington's Gene Therapy Data

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QURE

Nov 3, 2025, 10:01 AM EST - 3 months ago

uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QURE

Biotech is back. Here's why these rallying stocks belong in your portfolio now.

Nov 3, 2025, 9:58 AM EST - 3 months ago

Biotech is back. Here's why these rallying stocks belong in your portfolio now.

ABBV ALNY AMGN BMY LLY MBX MDGL

UniQure Stock Plummets 67% on Potential FDA Decision. Here's Why.

Nov 3, 2025, 8:11 AM EST - 3 months ago

UniQure Stock Plummets 67% on Potential FDA Decision. Here's Why.

FDA says clinical data for UniQure's Huntington's disease therapy not adequate

Nov 3, 2025, 7:18 AM EST - 3 months ago

FDA says clinical data for UniQure's Huntington's disease therapy not adequate

uniQure: 3-Year Huntington's Data Move AMT-130 From 'Promising' To 'Probable' (Rating Upgrade)

Oct 28, 2025, 1:55 PM EDT - 3 months ago

uniQure: 3-Year Huntington's Data Move AMT-130 From 'Promising' To 'Probable' (Rating Upgrade)

uniQure: Further Upside Likely As The Opportunity Becomes Better Understood

Oct 8, 2025, 3:33 PM EDT - 4 months ago

uniQure: Further Upside Likely As The Opportunity Becomes Better Understood

uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

Sep 29, 2025, 4:05 PM EDT - 4 months ago

uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

uniQure Announces Pricing of Upsized $300 Million Public Offering

Sep 25, 2025, 11:38 PM EDT - 4 months ago

uniQure Announces Pricing of Upsized $300 Million Public Offering

UniQure Stock's 248% Blastoff Was Just The Start — Ask Wall Street

Sep 25, 2025, 8:37 AM EDT - 4 months ago

UniQure Stock's 248% Blastoff Was Just The Start — Ask Wall Street

uniQure Stock Jumps On Positive News, But Risks Remain

Sep 25, 2025, 7:23 AM EDT - 4 months ago

uniQure Stock Jumps On Positive News, But Risks Remain

UniQure: How QURE Stock Rises 10x To $500?

Sep 25, 2025, 6:20 AM EDT - 4 months ago

UniQure: How QURE Stock Rises 10x To $500?

Here's why biotech UniQure's stock just tripled, and brought ClearPoint shares up with it

Sep 24, 2025, 4:37 PM EDT - 4 months ago

Here's why biotech UniQure's stock just tripled, and brought ClearPoint shares up with it

uniQure: Positive 3-Year AMT-130 Data Leads To Pre-BLA FDA Meeting And Beyond

Sep 24, 2025, 4:24 PM EDT - 4 months ago

uniQure: Positive 3-Year AMT-130 Data Leads To Pre-BLA FDA Meeting And Beyond

uniQure Announces $200 Million Proposed Public Offering

Sep 24, 2025, 4:06 PM EDT - 4 months ago

uniQure Announces $200 Million Proposed Public Offering

uniQure N.V. - Special Call

Sep 24, 2025, 1:03 PM EDT - 4 months ago

uniQure N.V. - Special Call

QURE stock skyrockets 200% on ‘three' big news

Sep 24, 2025, 11:20 AM EDT - 4 months ago

QURE stock skyrockets 200% on ‘three' big news

uniQure Stock Doubles On Promising Data From Huntington's Disease Trial

Sep 24, 2025, 10:23 AM EDT - 4 months ago

uniQure Stock Doubles On Promising Data From Huntington's Disease Trial

UniQure's brain disorder drug slows disease progression in trial

Sep 24, 2025, 7:28 AM EDT - 4 months ago

UniQure's brain disorder drug slows disease progression in trial

uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding

Sep 24, 2025, 7:10 AM EDT - 4 months ago

uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding

uniQure Announces Positive Topline Results from Pivotal Phase I/II Study of AMT-130 in Patients with Huntington's Disease

Sep 24, 2025, 7:05 AM EDT - 4 months ago

uniQure Announces Positive Topline Results from Pivotal Phase I/II Study of AMT-130 in Patients with Huntington's Disease

uniQure: Getting Nervous Ahead Of Critical Huntington's Gene Therapy Data

Sep 5, 2025, 4:57 PM EDT - 5 months ago

uniQure: Getting Nervous Ahead Of Critical Huntington's Gene Therapy Data

uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

Sep 5, 2025, 7:05 AM EDT - 5 months ago

uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

Jul 30, 2025, 11:07 AM EDT - 6 months ago

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

CAPR SRPT CABA NGNE NTLA RCKT

uniQure N.V. (QURE) Q2 2025 Earnings Call Transcript

Jul 29, 2025, 9:07 PM EDT - 6 months ago

uniQure N.V. (QURE) Q2 2025 Earnings Call Transcript

uniQure Announces Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

Jul 29, 2025, 7:05 AM EDT - 6 months ago

uniQure Announces Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

uniQure to Announce Second Quarter 2025 Financial Results

Jul 22, 2025, 7:05 AM EDT - 7 months ago

uniQure to Announce Second Quarter 2025 Financial Results

uniQure Announces Appointment of Kylie O'Keefe as Chief Customer and Strategy Officer

Jun 11, 2025, 8:00 AM EDT - 8 months ago

uniQure Announces Appointment of Kylie O'Keefe as Chief Customer and Strategy Officer

uniQure's AMT-130 Gene Therapy Warrants An Upgrade

May 28, 2025, 4:56 AM EDT - 8 months ago

uniQure's AMT-130 Gene Therapy Warrants An Upgrade

freddie04
freddie04 Feb. 3 at 8:41 PM
$QURE Ahhhhh …you’ll see ..early yet with loser Matt
0 · Reply
Longbuy1
Longbuy1 Feb. 3 at 5:59 PM
$QURE never forget these losers.
0 · Reply
stu4
stu4 Feb. 3 at 5:48 PM
$QURE you nailed it !!! More Matt BS…company ran by an ex stock broker ..OH WOW
0 · Reply
MAGA1717
MAGA1717 Feb. 3 at 5:25 PM
$QURE $CLPT 🤡🤡🤡 thx fo yo money asshat…
0 · Reply
CapitalGuidanceFramework
CapitalGuidanceFramework Feb. 3 at 4:57 PM
$QURE $EFX Healthcare and data services
0 · Reply
stu4
stu4 Feb. 3 at 4:00 PM
$QURE Matt made the call to his buddies GTFO !! Falling
1 · Reply
CliffordCapital
CliffordCapital Feb. 3 at 3:55 PM
$PLX poor folks at $SGMO .. there is a possibility that their Fabry therapy never makes it to the market.. obviously good for $PLX but sucks for Fabry patients. Only near term company with another Fabry treatmean is $QURE but their p2 data isn‘t until end of 2027 so I expect they are earliest in the market by the end of the decade…
3 · Reply
BigWickEnergy69
BigWickEnergy69 Feb. 3 at 3:53 PM
$QURE QURE is at WORLDSymposium this week presenting on Fabray data. Afterparties on Monday night get a bit loose as people jockey for position in the new group of colleagues. Some say there were loose lips on topics that one might use to impress colleagues…
1 · Reply
Doom_Gloom_AR
Doom_Gloom_AR Feb. 3 at 3:42 PM
$QURE https://en.hdbuzz.net/wp-content/uploads/2026/01/FOR-RELEASE-Skyhawk_SKY-0515-Nine-Month-Phase-1C-Patient-Data-1-27-26.pdf
1 · Reply
Longbuy1
Longbuy1 Feb. 3 at 3:36 PM
$QURE LOL at shorts
0 · Reply
MAGA1717
MAGA1717 Feb. 3 at 3:32 PM
$QURE 💪💪💪💪💪💪
0 · Reply
MF__DOOM
MF__DOOM Feb. 3 at 3:30 PM
$QURE $80-100 no less
0 · Reply
Longbuy1
Longbuy1 Feb. 3 at 2:52 PM
$QURE LMAO see you at 60$
0 · Reply
Longbuy1
Longbuy1 Feb. 3 at 1:44 PM
$QURE news will bring it to 60$
0 · Reply
waugusti
waugusti Feb. 3 at 12:49 PM
$QURE chart looks good. Algos will drive this to 30. This week?
0 · Reply
stu4
stu4 Feb. 3 at 12:14 PM
$QURE they already did , yesterday at the miraculous high , lol that they made !!! By being long, for their algo run and fooling you !!! Happy buying Matt’s bullshit
0 · Reply
Longbuy1
Longbuy1 Feb. 3 at 11:33 AM
$QURE short it and find out. 🤡
0 · Reply
Dkll303
Dkll303 Feb. 3 at 1:22 AM
$QURE Matt fcuked it up the last time hahaha Don’t count on him for anything..he is an ex lying stock broker
0 · Reply
Dkll303
Dkll303 Feb. 3 at 1:21 AM
$QURE Fastest liar to the exits …going back 4 years ..he disappeared at $25 ..just a liar
0 · Reply
Dkll303
Dkll303 Feb. 3 at 1:20 AM
$QURE Really stretching the truth , here .. Just Matt’s buddies from his stock days fcuking with you
1 · Reply
Longbuy1
Longbuy1 Feb. 2 at 10:45 PM
$QURE Leaks leaks! See you at 60$+
0 · Reply
Sabini
Sabini Feb. 2 at 10:24 PM
$QURE somebody knows something re typ A meeting ? Or acknowledgement that podcast with Huntington Disease advocat may increase pressure on FDA?
0 · Reply